Short interest in Intra-Cellular Therapies Inc (NASDAQ:ITCI) increased during the last reporting period, rising from 1.74M to 1.88M. This put 2.04% of the company's publicly available shares short.

Short interest for Intra-Cellular Therapies gives investors a sense of the degree to which investors are betting on the decline of Intra-Cellular Therapies's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 384.50K shares traded per day, it would take 4.9 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.